Laboratori 2019/2020 - Immunologia e Oncologia di Base e Applicate
4 BORSE A PROGETTO:
TONON GIOVANNI- Project-Based Fellowship BAIO1
Unit: Functional Genomics of Cancer
BAIO1: single-cell genomic approaches to unravel tumor heterogeneityIANNACONE MATTEO - Project-Based Fellowship BAIO2
Unit: Dynamics of immune responses
BAIO2: Determinants of T cell behavior within the cancerous liverIANNACONE MATTEO - Project-Based Fellowship BAIO3
Unit: Dynamics of immune responses
BAIO3: Defining intrahepatic T cell priming events responsible for defective T cell responsesFALCONE MARIKA - Project-Based Fellowship BAIO4
Unit: Experimental Diabetes
BAIO4: Exploiting a multi-omic data integration approach to assess the role of gut-related immune modulation in multiple sclerosis___________________________________________________________
9 borse FCSR-Fronzaroli sono destinate a candidati che optano per uno dei progetti accreditati per questa tipologia di borse.
La preferenza per una borsa FCSR-Fronzaroli dovrà essere indicata durante la compilazione del modulo elettronico per la sottomissione della domanda di ammissione, come riportato all'art. del bando di concorso.
I vincitori di una posizione con borsa FCSR- Fronzaroli o di una borsa libera devono scegliere il proprio progetto di ricerca tra quelli offerti per il Curriculum di 1° scelta.
Conclusa la seconda fase di assegnazione tutti i progetti qui sotto elencati, che riportano la dicitura FCSR-Fronzaroli ,che non sono stati scelti dai vincitori della suddetta borsa, potranno essere scelti durante le successive fasi di ammissione da tutti gli altri candidati.
AGRESTI ALESSANDRA - FCSR Fronzaroli
Unit: In Vivo Chromatin and Transcription
Understand the molecular mechanisms of anti-NF-kB drugs to improve Multiple Myeloma therapyBELLONE MATTEO - FCSR Fronzaroli
Unit: Cellular Immunology
Identification of the pathogenic crosstalk between gut microbiota and immune cells driving multiple myeloma progressionBOLETTA ALESSANDRA - FCSR Fronzaroli
Unit: Molecular Basis of Cystic Kidney Disorders
CHARACTERIZATION OF KEY METABOLIC ALTERATIONS IN RENAL CELL CARCINOMABRENDOLAN ANDREA - FCSR Fronzaroli
Unit: Lymphoid Organ Development and Function
1. Role of the stromal microenvironment in B-cell malignancies 2. Development and functional characterization of a human 3D leukemic microenvironment in a perfusion bioreactor systemUnit: Innovative Immunotherapies
1. Improving the Therapeutic Index of CAR-T cell therapy for solid tumours 2. Engineering better CAR-T cells for cancer therapyDE CURTIS IVAN - FCSR Fronzaroli
Unit: Cell Adhesion
Regulatory mechanisms of invadosome assembly and functionDEGANO MASSIMO - FCSR Fronzaroli
Unit: Biocrystallography
The molecular basis of autonomous signaling in chronic lymphocytic leukemiaDELLABONA PAOLO - FCSR Fronzaroli
Unit: Experimental Immunology
Adoptive immunotherapy of hepatic cancer metastasis with functionally engineered innate-like T cellsFALCONE MARIKA - FCSR Fronzaroli
Unit: Experimental Diabetes
Assessing the role of gut barrier integrity in the pathogenesis of autoimmune diabetesFOUSTERI GEORGIA - FCSR Fronzaroli
Unit: Regulation of Adaptive Immunity
Role of follicular helper T cells in the humoral immune alterations in patients with mutations in the Wiskott Aldrich Syndrome protein before and after hematopoietic stem cell transplantation or gene therapyUnit: Regulation of Adaptive Immunity
Immune therapy with genetically engineered regulatory T cells to establish tolerance in type 1 diabetesGREGORI SILVIA - FCSR Fronzaroli
Unit: Mechanisms of Peripheral Tolerance
Unraveling epigenetic mechanisms controlling immune toleranceMANFREDI ANGELO - FCSR Fronzaroli
Unit: Autoimmunity and vascular Inflammation
Mitochondrial DAMPs drive vascular inflammation and autoimmunityMONDINO ANNA - FCSR Fronzaroli
Unit: Lymphocyte Activation
Unlocking tumors to TCR/CAR engineered T cellsUnit: Transplant Immunology
Targeting the glucose transporter GLUT1 to control T cell activationMUZIO MARTA - FCSR Fronzaroli
Unit: Cell Signaling
Dissecting Toll-like receptors signaling pathways in B-cell lymphoid malignanciesOSTUNI RENATO - FCSR Fronzaroli
Unit: Genomics of the innate immune system
Mechanisms of suppression of inflammatory gene expression in macrophagesPOLI GUIDO - FCSR Fronzaroli
Unit: AIDS Immunopathogenesis
1. HIV-1 Infection of Macrophages: Role of M1/M2 Polarization in Reversible Proviral Latency 2. Immuno-Virological Dynamics Triggered by Anti-HIV Therapy SuspensionROVERE-QUERINI PATRIZIA - FCSR Fronzaroli
Unit: Innate Immunity and Tissue Remodelling
Role of complement in a murine experimental model of dermatomyositis (EDM)Unit: Innate Immunity and Tissue Remodelling
Mechanisms of inhibition of HIV mucosal transmission by antibodiesSESSA ALESSANDRO - FCSR Fronzaroli
Unit: Stem Cells & Neurogenesis
Generation and validation of an artificial transcription factor to epigenetically reprogram glioblastoma cellsSITIA GIOVANNI - FCSR Fronzaroli
Unit: Experimental Hepatology
Type I interferon subtypes with high in-vivo potency for the treatment of liver colorectal cancer metastasesTACCHETTI CARLO - FCSR Fronzaroli
Unit: CIS_Experimental Imaging Center
eIF2α-driven translation reprogramming as a therapeutic vulnerability in triplenegative breast cancerVAGO RICCARDO - FCSR Fronzaroli
Unit: Urological Research Institute
Targeted delivery of toxins for the treatment of bladder cancerVICENZI ELISA - FCSR Fronzaroli
Unit: Viral Pathogens and Biosafety
ZIKA virus cytopathic infection of neural progenitor cells and its exploitation as oncolytic virus for brain tumors